Insider Transactions in Q4 2020 at Prevail Therapeutics Inc. (PRVL)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 30
2020
|
Asa Abeliovich President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
89,037
-3.6%
|
$2,047,851
$23.02 P/Share
|
Dec 30
2020
|
Asa Abeliovich President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
125,793
+2.43%
|
$628,965
$5.22 P/Share
|